News

Source LDPath have further optimised their histopathology courier service to improve on their already market-leading turnaround times. The new and improved courier network has recently launched and will fully replace old courier routes by Monday, May 20th 2024.

Existing clients do not need to do anything and operations will continue as normal.

Samples will travel directly from clinic to laboratory – for a fast and seamless journey via the new courier, Nexus.

These changes will also allow new deliveries to the laboratory on Saturdays for even faster turnaround times.

We are excited to see that One Nucleus Corporate Patron, AstraZeneca, has announced an ambitious goal to achieve $80 billion in annual revenue by 2030, a significant increase from $45 billion in 2023. This growth will be driven by expanding their oncology, biopharmaceuticals and rare disease portfolios and launching 20 new medicines by the end of the decade. Additionally, AstraZeneca plans to sustain growth beyond 2030 by investing in transformative new technologies.

The Life Sciences Catalyst Business Lounge, designed to be a regional hotspot for start-ups and world-leading businesses in the life sciences sector, has been opened by Deloitte Cambridge.

The Life Sciences Catalyst Business Lounge is based within Deloitte Cambridge’s existing office and located on the 1st floor.

New drug discovery platform integrates computational approaches with molecular biology for development of novel degrader therapeutics

Cambridge, UK, 21 May 2024: PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™. The new phenotypic screening platform expands the Company’s capabilities in this emerging therapeutic modality to support the systematic discovery and development of novel molecular glue degraders (MGDs) for targeted protein degradation (TPD).